A simple blood test done immediately after cardiac surgery may provide an effective indication of a patient’s postoperative stroke risk. An acutely elevated blood urea nitrogen (BUN) level after an operation was “by far” the most powerful predictor of postcardiac surgical stroke in a case-control study.
The Society for Cardiovascular Angiography and Interventions’ (SCAI) 2015 convention will kick off May 6 with a session on state-of-the-art technologies, which will include keynote lectures by Christian Assad-Kottner, MD, of El Camino Hospital in Mountain View, Calif., and Peter J. Fitzgerald, MD, of Stanford University in California.
The FDA is warning cardiologists that patients can develop life-threatening symptomatic bradycardia when the hepatitis C drugs ledipasvir/sofosbuvir or sofosbuvir combined with another direct-acting antiviral are taken together with amiodarone.
As healthcare evolves into a more value-based system, physicians are increasingly taking the reins as leaders within healthcare systems, using their clinical background to direct stronger patient-centric care.
Boston Scientific’s implantable Watchman Left Atrial Appendage Closure Device finally won FDA approval to become an option to long-term warfarin therapy for high-risk patients with nonvalvular atrial fibrillation.
Former Intel executive Sean Maloney set off on a 5,000-mile cycling quest March 22 to raise awareness about stroke prevention. His Heart Across America campaign is a three-month fundraising trek from Palo Alto, Calif., to New York City.